Eli Lilly will build a $6 billion pharmaceutical manufacturing campus on 260 acres at the northeast corner of I-565 and Greenbrier Parkway — the largest industrial private investment in Alabama history. Announced December 2025, with the Huntsville City Council approving the development agreement in February 2026.
For anyone relocating to North Alabama, this is the most consequential economic news since Mazda Toyota. It also does something the defense sector cannot: it diversifies the metro away from federal appropriations entirely.
What the binding agreement actually commits Lilly to
This is the part most coverage skips. The $6 billion is the announcement figure. The development agreement the City Council approved in February 2026 binds Lilly to something more specific — and somewhat smaller.
| Item | Announced | Required by the agreement |
|---|---|---|
| Investment | "More than $6 billion" | At least $4.2 billion in construction and equipment |
| Jobs | 450 high-value positions | 449 jobs, average wage $54.20/hour |
| Facility size | Multi-building campus, 1M+ sq ft | 750,000 sq ft |
| Construction start | Site work "later this year" (2026) | By March 31, 2027 |
| Operations begin | ~48 months; production 2032 | By end of 2033 |
Development agreements set the floor a company must hit to keep its incentives, not the ceiling of what it intends to spend. A $4.2 billion binding minimum against a $6 billion announced figure is normal structuring, not a bait-and-switch.
But if you are making a relocation decision on the strength of this project, the agreement is the number with teeth. An average wage of $54.20 an hour is roughly $112,700 a year — genuinely strong, and above the Huntsville metro mean for architecture and engineering occupations.
The jobs, and who they are for
The 450 permanent roles are engineers, scientists, operations personnel and lab technicians. That mix matters because it is unlike almost everything else hiring at scale in this metro.
Every major defense employer here screens candidates through federal vetting before skills are ever assessed — ITAR "US person" status, security clearance sponsorship, or both. Lilly does neither.
Alongside Huntsville Hospital, this becomes one of the few large employers in the metro open to a chemical engineer, process technician or lab scientist with no defense background and no interest in acquiring one. For two-income households where only one partner can pass federal vetting, that is a meaningful change.
The plant will produce active pharmaceutical ingredients for small-molecule synthetic and peptide medicines — including orforglipron, Lilly's first oral GLP-1 receptor agonist for obesity. It is the third of four new US sites under a $27 billion Lilly manufacturing commitment. UAH and Calhoun Community College are both tailoring workforce programs toward it.
Why Huntsville won
Lilly selected the Greenbrier South site from more than 300 applications. CEO David Ricks cited proximity to the HudsonAlpha Institute for Biotechnology as a key driver, with research collaboration possibilities alongside workforce training. Utilities access, transportation, zoning and incentives rounded out the case.
That is worth sitting with. HudsonAlpha has been on the site-selection slide deck for Huntsville for years without landing something of this scale. It just did.
What it means if you are moving here
| Effect | What to expect |
|---|---|
| Greenbrier and Limestone County pressure | The site sits in the metro's fastest-growing corridor — Limestone County grew 14.14% from 2020 to 2024. Roughly 3,000 construction workers arrive before 450 permanent staff do. Expect accelerated residential development, and pressure on roads, utilities and schools. |
| Housing near the site | Greenbrier Preserve sits on Swancott Road just across I-565 from the plant site — the closest master-planned community to it. Worth understanding its Huntsville City Schools zoning before assuming a Madison address means Madison City Schools. |
| Diversification away from defense | Combined with SPX's $118M data-center cooling plant nearby, the metro is now capturing demand that has nothing to do with federal appropriations. For anyone weighing exposure to defense budget cycles, this is the most encouraging development in years. |
| Timeline reality | Production targets 2032. If you are relocating for a Lilly job, that is years out. Construction hiring is the near-term opportunity. |
Construction has not started. The binding deadline to begin is March 2027, and operations are not required until the end of 2033. Ricks projected roughly 48 months to operational once underway.
The same rule that applies to every defense program announcement applies here: relocate on a signed offer, not a press release. What this project legitimately changes is the metro's medium-term trajectory — not next quarter's job board.
What to watch
- Site work beginning. Mayor Battle said site work would start in 2026. That is the first real proof point.
- Orforglipron regulatory outcomes. The plant's ramp depends heavily on approvals for Lilly's oral GLP-1. Slower approvals mean a slower plant.
- Greenbrier infrastructure decisions. Road and utility commitments around the corridor will shape commute times for anyone buying nearby.
- UAH and Calhoun program launches. These signal what the hiring profile will actually look like.